Palliative symptom management in patients with mesothelioma

This is a recording of a session at the 2023 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous sponsors: Belluck and Fox, LLP; Maune Raichle Hartley French & Mudd, LLC (MRHFM); Polaris Pharmaceuticals, Inc.; Bristol Myers Squibb;  Merck; The Gori Law Firm; Ikena Oncology;  Early Lucarelli Sweeney & Meisenkothen; Novacure

Find other recorded sessions and more information at www.curemeso.org/symposium